Repurposing Pyronaridine as a novel inhibitor of heterodimeric ERCC1-XPF DNA endonuclease for targeted sensitization of colorectal cancer to platinum-based chemotherapeutics

Parnian Mehinrad is a Masters student in the faculty of pharmacy and pharmaceutical sciences, University of Alberta. Her area of research is drug delivery for cancer therapy.

свернуть